Patricia Bath was an American ophthalmologist and inventor who transformed cataract surgery and became the first African American woman to receive a patent for a medical device. Born on November 4, 1942, in Harlem, New York, she spent her career fighting preventable blindness through both technological innovation and public health advocacy. She died on May 25, 2019, at age 76.
Early Life and Medical Training
Bath grew up in Harlem, the daughter of a Trinidadian immigrant father who worked as a merchant seaman and a mother who was a domestic worker. Her parents encouraged her academic interests from an early age, and she showed a talent for science as a teenager. At just 16, she was selected to participate in a National Science Foundation summer research program at Yeshiva University, where she studied connections between nutrition, stress, and cancer.
She earned her bachelor’s degree in chemistry from Hunter College in 1964 and her medical degree from Howard University College of Medicine in 1968. During her medical training, she completed an internship at Harlem Hospital and a fellowship in ophthalmology at Columbia University. It was during this period, moving between Harlem Hospital (which served a predominantly Black community) and Columbia’s Eye Institute (which served a mostly white patient population), that she observed a striking disparity: blindness and visual impairment were far more common among Black patients. That observation shaped the rest of her career.
Creating Community Ophthalmology
Driven by the racial disparities she had witnessed firsthand, Bath proposed an entirely new discipline she called community ophthalmology. The field combines public health, community medicine, and clinical eye care to bring primary vision services to underserved populations. Rather than waiting for patients to arrive at a hospital, community ophthalmology sends trained volunteers into senior centers, daycare programs, and neighborhood clinics to test vision and screen for cataracts, glaucoma, and other sight-threatening conditions.
The approach has saved the sight of thousands of people whose problems would otherwise have gone undiagnosed. For children, the impact extends beyond health: identifying kids who need eyeglasses gives them a better chance of succeeding in school. Community ophthalmology is now practiced worldwide and remains one of Bath’s most far-reaching contributions, even if it receives less attention than her invention.
Pioneering Career at UCLA
In 1974, Bath joined the faculty of the ophthalmology department at what is now the David Geffen School of Medicine at UCLA, becoming its first female faculty member in that specialty. She held the appointment until 1987. During her time at UCLA’s Jules Stein Eye Institute, she was also the first African American woman to serve as a resident in ophthalmology at New York University and the first African American to complete a residency in ophthalmology at that institution. These firsts were not symbolic gestures. Bath was building credibility and access in a field where Black women were virtually absent, and she used her position to advocate for equitable eye care at every level.
Inventing the Laserphaco Probe
Bath’s most celebrated achievement is the Laserphaco Probe, a device that fundamentally changed how cataracts are removed. In 1988, the U.S. Patent and Trademark Office granted her U.S. Patent No. 4,744,360 for an “apparatus for ablating and removing cataract lenses,” making her the first African American woman to hold a patent for a medical device.
Before the Laserphaco Probe existed, cataract surgery relied on invasive manual extraction methods. Surgeons had to make relatively large incisions and physically remove the clouded lens, which meant longer recovery times, higher complication risks, and significant postoperative discomfort. Bath’s device replaced brute-force techniques with precision.
The probe works in two stages. First, a laser generates extremely concentrated light pulses that break the cataract into fragments. This step is critical because it allows the damaged lens to be removed without harming the delicate structures surrounding it. Carefully calibrated settings maximize the fragmentation while minimizing heat damage to nearby tissue. Once the cataract is broken apart, an ultrasonic tip takes over, using high-frequency sound waves to reduce the fragments to pieces smaller than one millimeter. The entire probe sits inside a sleeve equipped with irrigation and suction tubes that continuously cool the surgical site and remove debris.
The combination of laser fragmentation and ultrasonic removal made cataract surgery faster, safer, and minimally invasive. Surgical times dropped, recovery periods shortened, and success rates climbed. By making the procedure less complex and more reliable, the technology also made cataract treatment more accessible globally, particularly in regions with limited surgical infrastructure.
Restoring Sight Around the World
Bath did not simply patent her invention and move on. She used the Laserphaco Probe in humanitarian surgical missions, traveling to multiple countries to perform or supervise cataract surgeries on patients who had been blind for years, and in some cases decades. She reportedly restored sight to individuals who had been unable to see for over 30 years. UCLA’s tribute to her after her death noted that her work helped “restore or improve vision for millions.”
Her international work reinforced the philosophy behind community ophthalmology: that access to eye care should not depend on geography, race, or income. She viewed sight as a basic human right and spent her career trying to make that principle a reality through both invention and advocacy.
Legacy and Honors
Bath accumulated a remarkable list of firsts over her career: first African American woman to patent a medical device, first female faculty member in ophthalmology at UCLA, and a co-founder of the American Institute for the Prevention of Blindness, which championed the idea that eyesight is a fundamental right. She held patents in the United States, Japan, Canada, and several European countries for her laser cataract surgery technology.
Her influence extends well beyond her own research. The discipline she created, community ophthalmology, operates in countries around the world, and the surgical principles behind the Laserphaco Probe remain central to modern cataract treatment. Bath demonstrated that innovation in medicine is not only about building better tools but about asking who those tools are built to serve.